US EditionInsider Selling: PTC Therapeutics (NASDAQ:PTCT) CFO Sells $164,596.05 in Stock
CEO Matthew Klein and CFO Pierre Gravier reduced their holdings by 0.75% and 2.31% respectively, selling over $398,000 worth of shares in early January SEC filings.
2 Articles
2 Articles
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) CEO Sells $233,679.68 in Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) CEO Matthew Klein sold 3,016 shares of PTC Therapeutics stock in a transaction dated Wednesday, January 7th. The stock was sold at an average price of $77.48, for a total value of $233,679.68. Following the completion of the sale, the chief executive officer owned 396,967 shares of the company’s stock, valued at approximately $30,757,003.16. The trade was a 0.75% decrease in their ownership …
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) EVP Sells $49,742.16 in Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) EVP Lee Scott Golden sold 642 shares of the business’s stock in a transaction on Wednesday, January 7th. The shares were sold at an average price of $77.48, for a total transaction of $49,742.16. Following the transaction, the executive vice president directly owned 93,294 shares in the […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
